Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | SB-203580 | 4754 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | SB-203580 | 4754 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | SB-203580 | 4754 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | SB-203580 | 4754 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | pivmecillinam | 115163 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pivmecillinam | 115163 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | pivmecillinam | 115163 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | pivmecillinam | 115163 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pivmecillinam | 115163 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | pivmecillinam | 115163 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | pivmecillinam | 115163 | drug-path |
Asthma | R-HSA-444620 | map05310 | pivmecillinam | 115163 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | pivmecillinam | 115163 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | pivmecillinam | 115163 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | naftifine | 2148 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | naftifine | 2148 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | naftifine | 2148 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | naftifine | 2148 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | naftifine | 2148 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | bethanechol | 4780 | drug-path |